ARGX:NASDAQ
argenx SE - ADR
$928.44
arrow_downward
-0.22%(-2.08) 1D
$928.44
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 7, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGX...
Open
$932.08
High
$942.68
Low
$921.72
Mkt. cap
58.78B
Avg. vol.
259.69K
Volume
258.33K
P/E ratio
35.27
52-wk high
$1,072.75
52-wk low
$661.85
EPS
$26.32
Beta
0.45
Shares outstanding
62.89M
No. of employees
2K
Open
$932.08
High
$942.68
Low
$921.72
Mkt. cap
58.78B
Avg. vol.
259.69K
Volume
258.33K
P/E ratio
35.27
52-wk high
$1,072.75
52-wk low
$661.85
EPS
$26.32
Beta
0.45
Shares outstanding
62.89M
No. of employees
2K
News stories
From web sources and news partners
AD HOC NEWS
·
5 hours ago
Argenx stock after-hours: EUR 839.00, prior close EUR 828.90
Zacks
·
6 hours ago
HALO Expands ENHANZE Collaboration & Licensing Deal With ARGX
TradingView
·
7 hours ago
HALO Expands ENHANZE Collaboration & Licensing Deal With ARGX
AD HOC NEWS
·
8 hours ago
Argenx stock gained 1.93 percent as pipeline access expands
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE - ADR